Rapport Therapeutics
RAPP
#6197
Rank
NZ$1.21 B
Marketcap
$33.27
Share price
2.75%
Change (1 day)
N/A
Change (1 year)

Rapport Therapeutics (RAPP) - P/B ratio

P/B ratio as of December 2024 : 2.16

According to Rapport Therapeutics's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Rapport Therapeutics - P/B ratio (from 2024 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-312.26
2023-12-31N/A